Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine versus conventional bupivacaine serratus plane block after single-port thoracoscopic lung surgery
ChiCTR2500099429Phase 4Not yet recruiting
- Sponsor
- Quzhou People's Hospital
- Start
- Mar 2025
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of liposomal bupivacaine and bupivacaine in postoperative pain and bronchial carcinoma (2 arms), sponsored by Quzhou People's Hospital. Primary endpoint: NRS pain score at rest and during movement/cough. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
liposomal bupivacainebupivacaine
03
Conditions
postoperative painbronchial carcinoma
Beyond the preview
Go deeper on ChiCTR2500099429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500099429.